Washington, DC — Today, a federal judge in Ohio denied the Chambers of Commerce’s request for a nationwide preliminary injunction in one of the cases that seeks to stop Medicare from negotiating lower drug prices for millions of seniors. This ruling allows Medicare to continue the process of negotiating lower drug prices as scheduled.
The Chambers’ case is one of eight meritless lawsuits seeking to overturn the Negotiation Program, which is overwhelmingly popular among voters of all parties across the country, to protect drug companies’ outrageous profits. While drug companies rake in billions and force seniors to skip doses of life-saving medicines, they charge up to four times more in the U.S. than in other countries. Read more about the lawsuits brought by big drug companies and their allies here.
In response, Protect Our Care Chair Leslie Dach issued the following statement:
“This decision means that greed lost and hard-working Americans won. All these lawsuits are meritless and driven by nothing more than corporate greed. Seniors shouldn’t be forced to cut pills and skip doses of lifesaving medications while the drug companies rake in outrageous profits. For now, Judge Newman’s decision means that Medicare can move forward and negotiate with drug companies to make prescription drugs more affordable for millions, but we must remain vigilant. The drug companies will continue using every tool in their arsenal in all of these cases so that they can continue to charge whatever they want.”